X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (17) 17
female (16) 16
male (16) 16
adult (15) 15
middle aged (14) 14
drug therapy, combination (11) 11
aged (10) 10
hepatitis c (10) 10
gastroenterology & hepatology (9) 9
hepacivirus - genetics (9) 9
antiviral agents (8) 8
hepatitis (8) 8
hepatitis c virus (8) 8
interferon (8) 8
ribavirin (8) 8
treatment outcome (8) 8
adolescent (7) 7
cirrhosis (7) 7
clinical trials (7) 7
gastroenterology and hepatology (7) 7
genetic aspects (7) 7
genotype (7) 7
hepatitis c, chronic - drug therapy (7) 7
hiv (7) 7
hiv infections - drug therapy (7) 7
infection (7) 7
infectious diseases (7) 7
dosage and administration (6) 6
drug therapy (6) 6
patients (6) 6
research (6) 6
young adult (6) 6
antiviral agents - therapeutic use (5) 5
care and treatment (5) 5
combination therapy (5) 5
drug administration schedule (5) 5
hiv infection (5) 5
immunology (5) 5
initial treatment (5) 5
liver cirrhosis (5) 5
abridged index medicus (4) 4
aids/hiv (4) 4
anti-hiv agents - therapeutic use (4) 4
antiretroviral drugs (4) 4
antiviral agents - administration & dosage (4) 4
antiviral agents - adverse effects (4) 4
efficacy (4) 4
genotype & phenotype (4) 4
genotypes (4) 4
hepatitis c, chronic - virology (4) 4
hiv-1 (4) 4
human immunodeficiency virus--hiv (4) 4
interferon-alpha - adverse effects (4) 4
interferon-alpha - therapeutic use (4) 4
retreatment (4) 4
ribavirin - adverse effects (4) 4
safety (4) 4
sulfonamides - therapeutic use (4) 4
viral hepatitis (4) 4
abacavir (3) 3
adults (3) 3
chronic infection (3) 3
combination (3) 3
complications and side effects (3) 3
dolutegravir (3) 3
dose-response relationship, drug (3) 3
double-blind (3) 3
double-blind method (3) 3
efavirenz (3) 3
health aspects (3) 3
infections (3) 3
lamivudine (3) 3
liver diseases (3) 3
ns5a (3) 3
once-daily dolutegravir (3) 3
original (3) 3
original article (3) 3
original articles (3) 3
pegylated interferon (3) 3
pharmacokinetics (3) 3
prevalence (3) 3
raltegravir (3) 3
regimens (3) 3
ribavirin - administration & dosage (3) 3
ribavirin - therapeutic use (3) 3
sofosbuvir (3) 3
sulfonamides - administration & dosage (3) 3
trial (3) 3
viral load (3) 3
virus-infection (3) 3
[ sdv ] life sciences [q-bio] (2) 2
alanine (2) 2
alanine transaminase (2) 2
algorithms (2) 2
analysis (2) 2
anti-hiv agents - administration & dosage (2) 2
antiretroviral therapy, highly active - methods (2) 2
antiviral activity (2) 2
benzimidazoles - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9893, pp. 700 - 708
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 10/2017, Volume 17, Issue 10, pp. 1062 - 1068
Journal Article
Hepatology, ISSN 0270-9139, 08/2017, Volume 66, Issue 2, pp. 389 - 397
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 02/2018, Volume 67, Issue 2, pp. 514 - 523
This study assessed the efficacy and safety of ribavirin‐free coformulated glecaprevir/pibrentasvir (G/P) in patients with hepatitis C virus genotype 3... 
NATURAL PREVALENCE | FIBROSIS | VELPATASVIR | STEATOSIS | SOFOSBUVIR | RESISTANCE | HCV GENOTYPE | INFECTION | DACLATASVIR | GASTROENTEROLOGY & HEPATOLOGY | PROGRESSION | Cirrhosis | Hepatitis | Clinical trials | Interferon | Hepatitis C | Patients | Ribavirin | Genotypes | Original
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 2, pp. 364 - 369
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 67, Issue 2, pp. 263 - 271
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 2015, Volume 70, Issue 5, pp. 515 - 519
The SINGLE study was a randomized, double-blind, noninferiority study that evaluated the safety and efficacy of 50 mg dolutegravir + abacavir/lamivudine versus... 
Lamivudine | HIV | Abacavir | Dolutegravir | INFECTIOUS DISEASES | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | ADULTS | abacavir | dolutegravir | IMMUNOLOGY | lamivudine
Journal Article
Journal Article
Journal Article